IN IN263DELNP2015A

MONOCLONAL ANTIBODIES FOR USE IN DIAGNOSIS AND THERAPY OF CANCERS AND AUTOIMMUNE DISEASE

Publication no.

IN263DELNP2015A
Priority date
2012-07-10
Filing date
2015-01-12
Published
2015-06-12
Assignee
UNIV TEXAS [US]
Inventors

MOLLDREM JEFFREY [US], SERGEEVA ANNA [US]

Abstract

The specification describes the sequences for antibodies that recognize the HLA A2 restricted peptide PR 1 in the context of HLA presentation on the surface of cancer cells. Use of these antibodies in the diagnosis and treatment of cancer and immune related diseases are also provided.

Classification

A61K39/00AI
A61K39/395AI
A61K39/395
A61K45/06
A61K47/6851
A61K47/6871
A61K49/0058
A61P29/00
A61P35/00
A61P35/02
A61P35/04
A61P37/00

Source documents

View on Espacenet

Does this actually block you?

A document turning up in a search is not the same as a document that anticipates your claims. Our registered Patent Agents read the claims, not just the abstract, and tell you where you still have room.

Protect Your Invention

Bibliographic data via the European Patent Office's Open Patent Services (DOCDB) . Republished here for research and prior-art review. This page is not legal advice, and its presence in our index says nothing about the validity or enforceability of the document. For the Indian legal position (status, oppositions, renewals), see InPASS.